Company / Cash & Equivalents
OPKO HEALTH, INC. Cash & Equivalents History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$364.4M
FY2025
5-year range
$95.9M / $426.6M
FY2021-FY2025
Trend
-14.6%
vs FY2024
Sector context
#53 of 207
Health Care
What the data says
At $364M, OPKO HEALTH, INC.'s cash & equivalents ranks #53 of 207 in the Health Care sector. Cash & Equivalents has fluctuated over the past 10 years, ranging from $72M in FY2020 to $427M in FY2024.
Based on SEC 10-K filings.
$364M in FY2025 with a 5-year CAGR of +38.2%.
Improved from $96M to $364M over the past 2 years.
Health Care sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- +33.5%
- 5-Year CAGR
- +38.2%
- 10-Year CAGR
- -
Sector benchmark
#53 of 207 in Health CareTop 26% of 207This company $364.4M Sector average $669.5M
▼
-45.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +38.2%, indicating consistent growth.
- In FY2025, cash & equivalents decreased 14.6% year-over-year.
- Ranks #53 out of 207 companies in the Health Care sector.
- Peak cash & equivalents was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.08 (distress zone, below 1.8 threshold)
- Negative profit margin: -7.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $364.4M | -14.6% |
| FY2024 | $426.6M | +344.9% |
| FY2023 | $95.9M | -37.4% |
| FY2022 | $153.2M | +13.7% |
| FY2021 | $134.7M | +86.6% |
| FY2020 | $72.2M | -15.5% |
| FY2019 | $85.5M | -11.4% |
| FY2018 | $96.5M | +5.4% |
| FY2017 | $91.5M | -45.8% |
| FY2016 | $168.7M | -12.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026